Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Amortizatization of Intangibles (2020 - 2021)

Apellis Pharmaceuticals (APLS) has 2 years of Amortizatization of Intangibles data on record, last reported at $3000.0 in Q4 2021.

  • For Q4 2021, Amortizatization of Intangibles fell 99.98% year-over-year to $3000.0; the TTM value through Dec 2021 reached $113000.0, down 99.25%, while the annual FY2021 figure was $113000.0, 99.25% down from the prior year.
  • Amortizatization of Intangibles reached $3000.0 in Q4 2021 per APLS's latest filing, up from -$8000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $14.8 million in Q4 2020 and bottomed at -$242000.0 in Q2 2021.